Union Bancaire Privee UBP SA Buys Shares of 3,505 HCA Healthcare, Inc. (NYSE:HCA)

Union Bancaire Privee UBP SA purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 3,505 shares of the company's stock, valued at approximately $1,060,000.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Private Advisor Group LLC boosted its position in shares of HCA Healthcare by 2.5% in the 3rd quarter. Private Advisor Group LLC now owns 3,382 shares of the company's stock valued at $1,374,000 after purchasing an additional 84 shares during the period. International Assets Investment Management LLC boosted its position in shares of HCA Healthcare by 40,544.0% in the 3rd quarter. International Assets Investment Management LLC now owns 20,322 shares of the company's stock valued at $82,590,000 after purchasing an additional 20,272 shares during the period. Dakota Wealth Management acquired a new stake in HCA Healthcare during the 3rd quarter worth about $251,000. Mirae Asset Global Investments Co. Ltd. boosted its position in HCA Healthcare by 6.2% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,608 shares of the company's stock worth $7,504,000 after acquiring an additional 1,093 shares during the period. Finally, NorthCrest Asset Manangement LLC boosted its position in HCA Healthcare by 6.3% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 3,806 shares of the company's stock worth $1,547,000 after acquiring an additional 226 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Analyst Ratings Changes

A number of brokerages have commented on HCA. JPMorgan Chase & Co. restated a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Royal Bank of Canada cut their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Bank of America cut their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $385.67.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.60% of the company's stock.

HCA Healthcare Stock Performance

HCA traded up $0.64 during midday trading on Thursday, reaching $320.55. The company's stock had a trading volume of 1,788,584 shares, compared to its average volume of 1,694,602. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a market cap of $79.60 billion, a P/E ratio of 14.59, a PEG ratio of 1.10 and a beta of 1.64. The company has a fifty day simple moving average of $314.65 and a 200 day simple moving average of $350.12. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the firm posted $5.90 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.90%. HCA Healthcare's payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.